학술논문
Genomic characterisation of de novo EGFR copy number gain and its impact on the efficacy of first-line EGFR-tyrosine kinase inhibitors for EGFR mutated non-small cell lung cancer
Document Type
Article
Author
Xu, Yiquan ; Yan, Jingjing ; Zhou, Chengzhi ; Wu, Lin ; Wang, Haibo ; Zhao, Jun ; Zhou, Maolin ; Wang, Jingyi ; Zheng, Xinlong ; Zhang, Longfeng ; Jiang, Kan ; Zheng, Xiaobin ; Miao, Qian ; Wu, Shiwen ; Zou, Zihua ; lian, Rong ; He, Yuange ; Chen, Rongrong ; Yang, Shanshan ; Li, Yujing ; Chen, Sihui ; Lin, Gen
Source
In European Journal of Cancer July 2023 188:81-89
Subject
Language
ISSN
0959-8049
Abstract
Highlights •This is a multicenter, retrospective and real-world study.•The largest scale data to explore genomic profiles of de novo EGFR CNG.•EGFR CNG had no effect on the efficacy of first-line EGFR-TKI treatment.•NSCLC patients with EGFR CNG had a complex genomic profile.